{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:55:10Z","timestamp":1770512110031,"version":"3.49.0"},"reference-count":15,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.25-0633","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:08:16Z","timestamp":1770156496000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Pathological Complete Response Achieved with Colorectal Cancer-Based Chemotherapy for Locally Recurrent Cecal Neuroendocrine Carcinoma after Surgery: A Case Report"],"prefix":"10.70352","volume":"12","author":[{"given":"Kana","family":"Kajisako","sequence":"first","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-5519","authenticated-orcid":false,"given":"Taro","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"Nishibayashi","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Ishida","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Hobo","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Toshima","sequence":"additional","affiliation":[{"name":"Department of Oncology, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Oncology, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiro","family":"Inoue","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987; 5: 1502\u201322.","DOI":"10.1200\/JCO.1987.5.10.1502"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Shafqat H, Ali S, Salhab M, et al. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis. Dis Colon Rectum 2015; 58: 294\u2013303.","DOI":"10.1097\/DCR.0000000000000298"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Silva DJ, Dos Santos J, Vaz AP, et al. Rectal mixed adenoneuroendocrine carcinoma: Case report. Medicine (Baltimore) 2021; 100: e27348.","DOI":"10.1097\/MD.0000000000027348"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Watanabe J, Suwa Y, Ota M, et al. Clinicopathological and prognostic evaluations of mixed adenoneuroendocrine carcinoma of the colon and rectum: a case-matched study. Dis Colon Rectum 2016; 59: 1160\u20137.","DOI":"10.1097\/DCR.0000000000000702"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Morizane C, Machida N, Honma Y, et al. Effectiveness of etoposide and cisplatin vs irinotecan and cisplatin therapy for patients with advanced neuroendocrine carcinoma of the digestive system: the TOPIC-NEC Phase 3 randomized clinical trial. JAMA Oncol 2022; 8: 1447\u201355.","DOI":"10.1001\/jamaoncol.2022.3395"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zhang P, Li J, Li J, et al. Etoposide and cisplatin versus irinotecan and cisplatin as the first-line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: A randomized phase 2 study. Cancer 2020; 126(Suppl 9): 2086\u201392.","DOI":"10.1002\/cncr.32750"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 2004; 47: 163\u20139.","DOI":"10.1007\/s10350-003-0038-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Conte B, George B, Overman M, et al. High-grade neuroendocrine colorectal carcinomas: a retrospective study of 100 patients. Clin Colorectal Cancer 2016; 15: e1\u20137.","DOI":"10.1016\/j.clcc.2015.12.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Smith JD, Reidy DL, Goodman KA, et al. A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum. Ann Surg Oncol 2014; 21: 2956\u201362.","DOI":"10.1245\/s10434-014-3725-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Owaki S, Mori Y, Nakai S, et al. BRAF V600E-mutated colorectal neuroendocrine carcinoma effectively treated with a chemotherapy protocol for BRAF-mutated metastatic colorectal cancer. Intern Med 2024; 63: 1995\u20139.","DOI":"10.2169\/internalmedicine.2870-23"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021; 19: 839\u201368.","DOI":"10.6004\/jnccn.2021.0032"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology 2016; 103: 186\u201394.","DOI":"10.1159\/000443172"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hadoux J, Malka D, Planchard D, et al. Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma. Endocr Relat Cancer 2015; 22: 289\u201398.","DOI":"10.1530\/ERC-15-0075"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ogimi T, Sadahiro S, Kamei Y, et al. Distribution of neuroendocrine marker-positive cells in colorectal cancer tissue and normal mucosal tissue: consideration of histogenesis of neuroendocrine cancer. Oncology 2019; 97: 294\u2013300.","DOI":"10.1159\/000501521"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Rodr\u00edguez-Rem\u00edrez M, Del Puerto-Nevado L, Fern\u00e1ndez Ace\u00f1ero MJ, et al. Strong antitumor activity of bevacizumab and aflibercept in neuroendocrine carcinomas: in-depth preclinical study. Neuroendocrinology 2020; 110: 50\u201362.","DOI":"10.1159\/000500591"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.25-0633\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:42:42Z","timestamp":1770439362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.25-0633\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0633","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.25-0633"}}